The Potential Rise in the Price of Lipocine Inc. (LPCN) following insiders activity

In a filing, Lipocine Inc. revealed its Principal Accounting Officer Fogarty Krista acquired Company’s shares for reported $10750.0 on May 17. In the deal valued at $0.86 per share,12,500 shares were bought. As a result of this transaction, Fogarty Krista now holds 12,500 shares worth roughly $ 7875.0.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Then, Patel Mahesh V. bought 50,000 shares, generating $38,495 in total proceeds. Upon buying the shares at $0.77, the CEO and President now owns 1,303,090 shares.

Before that, Patel Mahesh V. bought 25,000 shares. Lipocine Inc. shares valued at $27,250 were divested by the CEO and President at a price of $1.09 per share. As a result of the transaction, Patel Mahesh V. now holds 1,253,090 shares, worth roughly $0.79 million.

Cantor Fitzgerald initiated its Lipocine Inc. [LPCN] rating to an Overweight in a research note published on Tuesday, June 24, 2021; the price target was $3. PT values the company’s stock at a premium of 79.0 to its Tuesday closing price. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who increased its forecast for the stock in early December from “a Neutral” to “a Buy”. H.C. Wainwright also remained covering LPCN and reiterated its “Buy” recommendation on January 12, 2018. Canaccord Genuity revised its rating on January 11, 2018. It rated LPCN as “a Hold” which previously was an “a Buy”.

Price Performance Review of LPCN

On Tuesday, Lipocine Inc. [NASDAQ:LPCN] saw its stock fall -10.27% to $0.63. On the same session, the stock had its day’s lowest price of $0.63, but rose to a high of $0.7282. Over the last five days, the stock has lost -12.83%. Lipocine Inc. shares have fallen nearly -36.23% since the year began. Nevertheless, the stocks have fallen -53.87% over the past one year. While a 52-week high of $1.89 was reached on 03/25/22, a 52-week low of $0.70 was recorded on 08/16/22. SMA at 50 days reached $0.7933, while 200 days put it at $1.0310. A total of 1.05 million shares were traded, compared to the trading of 0.32 million shares in the previous session.

Levels Of Support And Resistance For LPCN Stock

The 24-hour chart illustrates a support level at 0.5986, which if violated will result in even more drops to 0.5652. On the upside, there is a resistance level at 0.6968. A further resistance level may holdings at 0.7616. The Relative Strength Index (RSI) on the 14-day chart is 25.92, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0661, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.05%. Stochastics %K at 2.65% indicates the stock is a buying.

How much short interest is there in Lipocine Inc.?

A steep rise in short interest was recorded in Lipocine Inc. stocks on Jul 14, 2022, dropping by 90000.0 shares to a total of 2.25 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 2.34 million shares. There was a decline of -4.0%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.61% of the overall stock float, the days-to-cover ratio (short ratio) fell to 14.98.

Lipocine Inc. [LPCN] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 3,768,535 shares, or roughly 4.26% of the outstanding LPCN shares. In other words, the investor’s shares have fallen by 0 from its previous 13-F filing of 3768535.0. Additionally, BlackRock Fund Advisors increased 3.12% of its stake after which the total value it holdings stand at $1,201,471, while Wealth Effects LLC reduced -0.70% of its stake to hold $1.11 million in the firm. Over the last quarter, Geode Capital Management LLC purchased 9,024 shares of Lipocine Inc., while Marshall Wace LLP bought 562,670 shares. At present, Two Sigma Investments LP is holding 360,070 shares valued at $0.27 million. SSgA Funds Management, Inc. owned 327,405 shares of the company at the time of its most recent 13F filing, worth $0.25 million.

According to FactSet, Lipocine Inc.’s share price will average $3.33 in the next year, based on opinions of analysts polled by the firm. This is up nearly 257.14 percent from its previous closing price of $0.70. Analysts expect Lipocine Inc. stock to reach the higher price of $5.50, while the lowest price estimate is $2.00. However, 2 analysts have rated LPCN stock as a Buy in their predictions for 2022.


Please enter your comment!
Please enter your name here